Chemistry: analytical and immunological testing – Involving an insoluble carrier for immobilizing immunochemicals – Carrier is organic
Patent
1982-07-01
1986-08-05
Marantz, Sidney
Chemistry: analytical and immunological testing
Involving an insoluble carrier for immobilizing immunochemicals
Carrier is organic
436536, 436805, 436808, 436815, 436823, G01N 3353
Patent
active
046043659
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
Therapeutic monitoring of various agents present in serum and other body fluids is a rapidly growing segment of the clinical laboratory testing field. With therapeutically effective agents, the purpose of the monitoring is to indicate adjustments in dosage so as to maintain a patient at a therapeutically effective drug level. Below this level, the agent may be toxic. Such monitoring is, as will be recognized, important not only for following changes in levels of useful therapeutic agents, but also for ascertaining levels of a wide variety of physiologically active substances which may be present in body fluids including, for example, vitamins, enzymes and hormones.
Methods available for the fast and accurate quantitative or qualitative determination of biologically active substances, at low concentrations are limited in number. The physicians diagnosis of the patient or confirmation of the diagnosis frequently involves the detection and/or quantitation of one or more substances in body fluids. The ability to detect rapidly in body fluids the presence and amounts of such materials is often critical to the patient's life.
Several methods have, in the past, been used for the assay of body fluids, notably radioimmunoassay, thin layer chromatography, enzyme immunoassay and fluorescence immunoassay systems. The use of a radioimmunoassay technique suffers from several disadvantages among which are the hazards associated with or inherent in radioactive materials, associated handling problems, instability, the need for expensive equipment for the assays and the difficulties associated with the manipulation and separation of the free and bound forms of the raidoactive materials. Thin layer chromatography is often quite slow in the development of the chromatogram, is sensitive to the presence of a variety of interfering factors and suffers from the lack of reporducibility or reliability. The use of enzyme or fluorescence immunoassay requires dealing with, and knowledge of very complicated chemistry involved in their preparation, storage and usage of the required reagents. Also, the method is sensitive to variations in environmental conditions, so that the methods have not proven entirely satisfactory to the users. Nephelometry has also been employed but the incubation times required have limited the practicality of the procedure, especially for automation. Additionally, the procedure requires the use of special equipment which is not routinely avaliable in commercial laboratories. Additionally, unless the laser nephelometer is employed interference noise or background effects are so bothersome that the technique cannot be applied directly to serum. Additionally, they cannot be used at low wavelengths where one would obtain best sensitivity because of the unavoidable increase in output power which renders them dangerous. (Deverill and Reiner, Journal of Immunological Methods 38 (1980) 191-204, at page 195).
The Invention
A procedure has now been discovered which substantially alleviates the problems aforesaid and makes possible the detection and accurate determination of small amounts of therapeutic drugs and other low molecular weight haptens in various body fluids and other samples. In accordance with the procedure, a competitive assay is set up for available antibody sites between the hapten, the concentration of which is to be determined and the same hapten conjugated to a carrier.
The process of the invention will be principally employed for the determination of hapten concentrations in mammalian serum. It is, however, applicable to the determination of hapten concentrations in a variety of liquid samples including, for example, human serum and plasma, urine, spinal fluid, amnionic fluid, etc.
The immunoprecipitation assay procedure of the invention may be applied to low molecular weight physiologically active substances, which for convenience are termed "haptens" in this description and claims. Haptens have been generally defined as protein-free substances with chemical configurat
REFERENCES:
patent: Re29169 (1977-04-01), Schuurs
patent: 3489522 (1970-01-01), McConnell
patent: 3654090 (1972-04-01), Schuurs
patent: 3690834 (1972-09-01), Goldstein
patent: 3791932 (1974-02-01), Schuurs
patent: 3817837 (1974-06-01), Rubenstein
patent: 3839153 (1974-10-01), Schuurs
patent: 3850752 (1974-11-01), Schuurs
patent: 3875011 (1975-04-01), Rubenstein
patent: 3879262 (1975-04-01), Schuurs
patent: 3935074 (1976-01-01), Rubenstein
patent: 3976763 (1976-08-01), Spector
patent: 4016043 (1977-04-01), Schuurs
patent: 4038143 (1977-07-01), Juni
patent: 4066744 (1978-01-01), Price
patent: 4150949 (1979-04-01), Smith
patent: 4152411 (1979-05-01), Schall
patent: 4230683 (1980-10-01), Decker
patent: 4401765 (1983-08-01), Craig
Wu, J. W. et al., Clinical Chemistry, 27(6), Abstract 341, 1092 (1981).
Dugan, S. et al., Clinical Chemistry, 28(5), 1190-1191 (1982).
Wu, J. W. et al., Clinical Chemistry, 28(4), 659-661 (1982).
I. Deverill et al., J. Immunol. Methods, 38, 191-204 (1980).
T. Nishikawa et al., Clinica Chimica Acta, 91, 59-65 (1979).
T. Nishikawa et al., J. Immunol. Methods, 29, 85-89 (1979).
P. R. Finley et al., Clin. Chem., 27(3), 405-409 (1981).
"Automated Immunoanalysis", Part 1, R. F. Ritchie, ed., Chapter 15 by J. Gauldie et al., Marcel Dekker, New York, 1978.
O'Neill Sean P.
Wu Joseph
Electro-Nucleonics, Inc.
Marantz Sidney
LandOfFree
Immunoprecipitation assay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoprecipitation assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoprecipitation assay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-969036